Aminoglycosides Market - Growth, Trends, and Forecast (2019 - 2024)

The market is segmented by Product (Neomycin, Tobramycin, Gentamycin, Streptomycin, Kanamycin, Paromomycin, Amikacin, Verdamicin, Astromicin, Hygromycin B), Route of Administration, Application, and Geography.

Market Snapshot

amino1
Study Period:

2016-2024

Base Year:

2018

Fastest Growing Market:

Europe

Largest Market:

North America

CAGR:

4.2%

Key Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

The global aminoglycosides market size is expected to witness a growth of over 4.3% CAGR over the forecast period, owing to the increasing burden of animal disease outbreaks leading to high utilization of antibiotics.

Moreover, this class of antibiotics is found to be effective even when bacterial inoculum is large, and are frequently used as a second line of defense against basic infection resistant to basic antibacterials. Additionally, reduction in the prescription rate of aminoglycoside antibiotics due to side effects associated with the usage of these drugs that include severe ototoxicity, nephrotoxicity, and neuromuscular blockade is expected to affect the market growth negatively.

Scope of the Report

As per the scope of the report, aminoglycosides are highly potent, antibiotics with several properties for the treatment of life-threatening infections. Aminoglycosides have concentration-dependent bactericidal activity by binding to the 30S ribosome that inhibits bacterial protein synthesis.

Product
Neomycin
Tobramycin
Gentamicin
Amikacin
Paromomycin
Streptomycin
Kanamycin
Other Aminoglycosides
Route of Administration
Parenteral
Intra-mammary
Topical
Oral
Application
Veterinary
Skin Infection
Respiratory Diseases
UTI & Pelvic Diseases
Other Diseases
Geography
North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Gentamicin Accounted for the Largest Share in the Global Market

Neomycin, streptomycin, gentamicin, kanamycin, tobramycin, amikacin, and others are included in the product categorization of aminoglycosides. Streptomycin is a first level antibacterial used for the treatment of tuberculosis. Aminoglycosides used in the treatment of MDR-TB include kanamycin capreomycin and amikacin.

Gentamicin is the agent of choice for major bacterial infections amongst others. Tobramycin has been found to be slightly more effective against Pseudomonas aeruginosa infections. Amikacin and gentamicin find maximum usage in veterinary medicine. Gentamicin is indicated in perinatal complications, sepsis, acute/chronic renal disease, labor or neonatal complications, diabetes, and UTI/pyelonephritis. Gentamicin forms the first line of treatment for many disorders in both developing and developed markets. Its usage is particularly high in developing regions where older gentamicin is a cost-effective and efficacious drug for many infectious diseases. Thus, its demand is consistently growing for a range of bacterial infection related diseases, with several players using it in combinations.

 

Aminoglycosides Market - imgae 3

To understand key trends, Download Sample Report

North America dominates the global aminoglycoside market

Geographically the aminoglycoside market is classified into North America, South America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the global aminoglycoside market in terms of value due to increasing incidence of bacterial infections. The growing demand for early-phase diagnosis and treatment of infectious diseases is expected to drive the growth of the aminoglycoside market in North America. According to the 2017 data published by the Centres for Disease Control & Prevention (CDC), in 2016 the total approximate number of visits in the US, to physician offices for infectious diseases was 16.8 million. The increasing incidence rate and high patient-visit volume for infectious diseases is the primary driver for North America's largest share in Aminoglycoside market

Europe is the second largest market for aminoglycoside in terms of value as there are favorable government policies regarding health care infrastructure and awareness of the population.

amino3

To understand geography trends, Download Sample Report

Competitive Landscape

The market studied is composed of a large number of players and includes both small and large pharmaceutical manufactureres. Additionally, the increasing antibiotic resistance has prompted many early stage biotechnology enterprises to enter this market. The expiry of patent exclusivity has led to large scale generic manufacturing of aminoglycosides, particularly in developing region of Asia-Pacific.

 

Major Players

  1. Kremoint Pharma Pvt. Ltd
  2. Vega Pharma Ltd.
  3. HuvePharma
  4. Yi Chang Sanxia Pharmaceutical Co., Ltd.
  5. Medico Remedies Ltd.

* Complete list of players covered available in the table of contents below

p3

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Incurable Status of the Disease

      2. 4.2.2 Global increase in Aging Population

      3. 4.2.3 Increasing Prevalence of Brain Disorders

    3. 4.3 Market Restraints

      1. 4.3.1 Adverse and Toxic Reactions Associated with Aminoglycosides

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Product

      1. 5.1.1 Neomycin

      2. 5.1.2 Tobramycin

      3. 5.1.3 Gentamicin

      4. 5.1.4 Amikacin

      5. 5.1.5 Paromomycin

      6. 5.1.6 Streptomycin

      7. 5.1.7 Kanamycin

      8. 5.1.8 Other Aminoglycosides

    2. 5.2 Route of Administration

      1. 5.2.1 Parenteral

      2. 5.2.2 Intra-mammary

      3. 5.2.3 Topical

      4. 5.2.4 Oral

    3. 5.3 Application

      1. 5.3.1 Veterinary

      2. 5.3.2 Skin Infection

      3. 5.3.3 Respiratory Diseases

      4. 5.3.4 UTI & Pelvic Diseases

      5. 5.3.5 Other Diseases

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 US

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 UK

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Alfasan International BV

      2. 6.1.2 Hangzhou Uniwise International Co., Ltd.

      3. 6.1.3 HuvePharma

      4. 6.1.4 Jiangxi Bolai Pharmacy Co., Ltd.

      5. 6.1.5 Kremoint Pharma Pvt. Ltd

      6. 6.1.6 Medico Remedies Pvt. Ltd

      7. 6.1.7 Medson Pharmaceuticals

      8. 6.1.8 Vega Pharma Ltd.

      9. 6.1.9 Xian Wison Biological Technology Co., Ltd.

      10. 6.1.10 Yi Chang Veterinary Medicine Factory

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments (Partnerships, M&A and others)

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please Enter a Valid Message!


Complete your payment details below

Shipping & Billing Information

Payment Information